MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT applied for Dosimetry of Radiopharmaceutical Therapy.
(2016) In Journal of Nuclear Medicine 57(1). p.151-162- Abstract
- Accuracy of absorbed dose calculations in personalized internal radionuclide therapy is directly related to the accuracy of the activity (or activity concentration) estimates obtained at each of the imaging time points. MIRD Pamphlet No. 23 presented a general overview of methods that are required for quantitative SPECT imaging. The present document is next in a series of isotope-specific guidelines and recommendations that follow the general information that was provided in MIRD 23. This paper focuses on 177-Lu (Lutetium) and its main application in radiopharmaceutical therapy.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8152143
- author
- Ljungberg, Michael LU ; Celler, Anna ; Konijnenberg, Mark W ; Eckerman, Keith F ; Dewaraja, Yuni K and Sjögreen Gleisner, Katarina LU
- organization
- publishing date
- 2016
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Nuclear Medicine
- volume
- 57
- issue
- 1
- pages
- 151 - 162
- publisher
- Society of Nuclear Medicine
- external identifiers
-
- pmid:26471692
- wos:000367862700026
- scopus:84958616819
- pmid:26471692
- ISSN
- 0161-5505
- DOI
- 10.2967/jnumed.115.159012
- language
- English
- LU publication?
- yes
- id
- b7bfa622-4d04-454b-8e66-908a6a4b33c4 (old id 8152143)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26471692?dopt=Abstract
- date added to LUP
- 2016-04-01 11:04:41
- date last changed
- 2024-11-20 00:40:42
@article{b7bfa622-4d04-454b-8e66-908a6a4b33c4, abstract = {{Accuracy of absorbed dose calculations in personalized internal radionuclide therapy is directly related to the accuracy of the activity (or activity concentration) estimates obtained at each of the imaging time points. MIRD Pamphlet No. 23 presented a general overview of methods that are required for quantitative SPECT imaging. The present document is next in a series of isotope-specific guidelines and recommendations that follow the general information that was provided in MIRD 23. This paper focuses on 177-Lu (Lutetium) and its main application in radiopharmaceutical therapy.}}, author = {{Ljungberg, Michael and Celler, Anna and Konijnenberg, Mark W and Eckerman, Keith F and Dewaraja, Yuni K and Sjögreen Gleisner, Katarina}}, issn = {{0161-5505}}, language = {{eng}}, number = {{1}}, pages = {{151--162}}, publisher = {{Society of Nuclear Medicine}}, series = {{Journal of Nuclear Medicine}}, title = {{MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT applied for Dosimetry of Radiopharmaceutical Therapy.}}, url = {{http://dx.doi.org/10.2967/jnumed.115.159012}}, doi = {{10.2967/jnumed.115.159012}}, volume = {{57}}, year = {{2016}}, }